Saturday 17 October 2026
Export AMWL’s income statement to Excel — free account
American Well Corporation
AMWL Healthcare Health Information Services
American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024. In the quarter to June 2026, revenue fell 26.6%, EPS grew 52.4% and free cash flow grew 266.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
11.68
0.70
−5.65%
Follow AMWL
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | 426.80 | 113.40 | 50.40 | 18.50 | 5.00 | 3.71 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | 836.00 | 875.00 | 126.00 | 85.50 | 31.20 | 12.95 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | 686 | 812 | 1,035 | 1,035 | 1,104 | 877 | 562 | ||||
| Revenue/emp, $m | — | — | 0.00 | 0.22 | 0.30 | 0.24 | 0.27 | 0.23 | 0.29 | 0.44 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | 114 | 149 | 245 | 253 | 277 | 259 | 254 | 249 | ||||
| Gross margin, % | — | — | 48.57 | 46.27 | 36.07 | 41.27 | 42.13 | 36.58 | 38.90 | 53.29 | |||||
| EBT | — | — | (52) | (89) | (226) | (179) | (270) | (673) | (207) | (93) | |||||
| EBT margin, % | — | — | (45.91) | (59.90) | (92.06) | (70.82) | (97.31) | (259.69) | (81.29) | (37.24) | |||||
| Net income | — | 0 | (52) | (88) | (229) | (177) | (272) | (679) | (213) | (95) | |||||
| Depreciation | — | — | 7 | 10 | 12 | 19 | 28 | 471 | 36 | 38 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | 56.16 | 72.37 | 49.53 | 19.90 | 20.22 | 18.23 | 16.96 | 15.54 | ||||
| Earnings | — | — | (25.78) | (42.96) | (45.40) | (13.80) | (19.80) | (47.60) | (13.88) | (5.96) | |||||
| Cash flow | — | — | (36.47) | (39.81) | (22.71) | (11.14) | (14.03) | (10.44) | (8.49) | (4.11) | |||||
| Capex | — | — | (0.94) | (0.65) | (0.67) | (0.04) | (0.76) | (1.07) | (1.01) | 0.00 | |||||
| Free cash flow | — | — | (37.41) | (40.46) | (23.38) | (11.19) | (14.79) | (11.51) | (9.50) | (4.11) | |||||
| Book value | — | — | 0.00 | (136.54) | 251.65 | 99.25 | 79.06 | 33.79 | 21.08 | 15.44 | |||||
| Shares, m | — | — | 2 | 2 | 5 | 13 | 14 | 14 | 15 | 16 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| P/S | — | — | 0.00 | 0.00 | 10.23 | 6.07 | 2.79 | 1.59 | 0.43 | 0.32 | |||||
| P/B | — | — | 0.00 | 0.00 | 2.01 | 1.22 | 0.71 | 0.86 | 0.34 | 0.32 | |||||
| EV/Sales | — | — | 0.00 | 0.00 | 5.98 | 3.12 | 0.85 | 0.15 | (0.47) | (0.42) | |||||
| EV/FCF | — | — | (5.92) | (5.92) | (12.66) | (5.55) | (1.16) | (0.25) | 0.84 | 1.57 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | (74) | (82) | (112) | (142) | (192) | (148) | (127) | (66) | ||||
| Capex | — | — | (2) | (1) | (3) | (1) | (10) | (15) | (15) | 0 | |||||
| Free cash flow | — | — | (76) | (83) | (116) | (142) | (203) | (164) | (143) | (66) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | 210 | 117 | 992 | 686 | 513 | 356 | 206 | 173 | ||||
| Total debt | — | — | — | 13 | 7 | 17 | 15 | — | — | — | |||||
| Net debt | — | — | (261) | (178) | (1,043) | (746) | (539) | (372) | (228) | (182) | |||||
| Shareholders’ equity | — | — | — | (281) | 1,246 | 1,261 | 1,084 | 480 | 316 | 248 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | 0.00 | (34.88) | (23.92) | (12.49) | (20.31) | (74.72) | (40.59) | (25.19) | ||||
| ROIC | — | — | 0.00 | 0.00 | (69.84) | (21.76) | (31.62) | (400.00) | (154.63) | (100.51) | |||||
| ROE | — | — | 19.55 | 34.00 | (46.50) | (14.07) | (23.07) | (86.34) | (52.27) | (33.93) | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
American Well Corporation vs peers in Health Information Services (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| CARL Carlsmed, Inc. | $380.9M | — (loss-making) | — (loss-making) | +56.75% (above 0%: growing) | n/m | −6.84% (below 0%: shrinking) | 76.78% | (58.27%) | Compare |
| CSLT Castlight Health, inc. | $332.4M | — (loss-making) | — (loss-making) | −0.86% (below 0%: shrinking) | n/m | +106.49% (above 0%: growing) | 66.20% | (5.42%) | Compare |
| SPOK Spok Holdings, Inc. | $224.5M | 17.7× | 16.2× | −1.89% (below 0%: shrinking) | −9.09% (below 0%: shrinking) | −2.00% (below 0%: shrinking) | 80.47% | 15.50% | Compare |
| AMWL American Well Corporation | $210.6M | — (loss-making) | — (loss-making) | −26.59% (below 0%: shrinking) | n/m | +266.38% (above 0%: growing) | 52.95% | (18.36%) | |
| SY So-Young International Inc. Sponsored ADR | $198.9M | — (loss-making) | 12.8× | +40.84% (above 0%: growing) | n/m | −798.37% (below 0%: shrinking) | 44.11% | (8.64%) | Compare |
| OPRX OptimizeRx Corp. | $166.7M | 35.4× | 23.0× | −29.77% (below 0%: shrinking) | n/m | +89.86% (above 0%: growing) | 76.51% | (0.43%) | Compare |
| DH Definitive Healthcare Corp. | $144.3M | — (loss-making) | — (loss-making) | −9.14% (below 0%: shrinking) | n/m | +21.44% (above 0%: growing) | 73.45% | (12.23%) | Compare |
| HCAT Health Catalyst, Inc. | $135.5M | — (loss-making) | — (loss-making) | −12.68% (below 0%: shrinking) | n/m | +64.26% (above 0%: growing) | 49.46% | (51.75%) | Compare |
| LFMD LifeMD, Inc. | $118.6M | — (loss-making) | — (loss-making) | −3.55% (below 0%: shrinking) | n/m | −247.52% (below 0%: shrinking) | 88.82% | (15.08%) | Compare |
| Median of peers | $182.8M | — | 16.2× | −2.72% | — | +9.72% | 74.98% | (10.43%) |
American Well Corporation (AMWL) key facts
- Concern: American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024.
- Concern: American Well Corporation reported a net loss of $95.0 million, or a loss of $5.96 per share, for fiscal 2025.
- American Well Corporation (AMWL) is a Health Information Services company in the Healthcare sector, listed on the New York Stock Exchange.
- As of October 16, 2026, AMWL traded at $11.68, a market capitalization of $210.6 million.
- Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 0.9× sales.
- Return on equity was −33.9% and debt-to-equity 0.00.
- Its Piotroski F-score is 6 out of 9 and its Altman Z-score is −7.95 (distress zone) for fiscal 2025.
American Well Corporation (AMWL) Latest News
No news at this impact. Lower the threshold for more.